"The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma" details the importance of FAIR data principles (Findable, Accessible, Interoperable, Reusable) for building reliable AI systems in the pharmaceutical sector.
Why It Matters
Forget the shiny AI tools for a moment. If your data isn't FAIR, your AI will be costly, unreliable, and likely non-compliant with the EU AI Act. For a mid-sized European pharma or CRO, this isn't about new tech; it's about getting your house in order. Without FAIR data, you're building on sand.
What To Do About It
I can conduct a rapid data readiness assessment for your existing data infrastructure and outline a practical FAIR data strategy, fully compliant with GDPR and the EU AI Act, in 2-3 weeks.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026